Will you have Red face with Treprostinil - from FDA reports

Summary

Red face is found among people who take Treprostinil, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Opsumit, and have Primary pulmonary hypertension. This study is created by eHealthMe based on reports of 1,986 people who have side effects when taking Treprostinil from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on treprostinil (the active ingredients of Treprostinil) and Treprostinil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Red face are also considered in the study.

What is Treprostinil?

Treprostinil has active ingredients of treprostinil. (latest outcomes from Treprostinil 1,986 users)

What is Red face?

Red face has been reported by people with multiple sclerosis, high blood cholesterol (latest reports from 80,061 Red face patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 20, 2019

1,986 people reported to have side effects when taking Treprostinil.
Among them, 82 people (4.13%) have Red face


Number of reports submitted per year:

Could Treprostinil cause Red face?

Time on Treprostinil when people have Red face *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 100 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Red face when taking Treprostinil *:

  • female: 69.51 %
  • male: 30.49 %

Age of people who have Red face when taking Treprostinil *:

  • 0-1: 0.0 %
  • 2-9: 2.63 %
  • 10-19: 3.95 %
  • 20-29: 5.26 %
  • 30-39: 3.95 %
  • 40-49: 15.79 %
  • 50-59: 25.0 %
  • 60+: 43.42 %

Top conditions involved for these people *:

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 62 people, 75.61%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 16 people, 19.51%
  3. Depression: 3 people, 3.66%
  4. Wheezing (a high-pitched whistling sound made while you breath): 2 people, 2.44%
  5. Pain: 2 people, 2.44%
  6. Headache (pain in head): 2 people, 2.44%
  7. Cough: 2 people, 2.44%
  8. Cor Pulmonale Chronic (long lasting enlargement of the right ventricle of the heart): 2 people, 2.44%
  9. Stress And Anxiety: 1 person, 1.22%
  10. Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 1.22%

Top co-used drugs for these people *:

  1. Opsumit: 30 people, 36.59%
  2. Tracleer: 23 people, 28.05%
  3. Coumadin: 20 people, 24.39%
  4. Adcirca: 18 people, 21.95%
  5. Revatio: 13 people, 15.85%
  6. Remodulin: 10 people, 12.20%
  7. Veletri: 9 people, 10.98%
  8. Adempas: 6 people, 7.32%
  9. Letairis: 6 people, 7.32%
  10. Uptravi: 6 people, 7.32%

Top other side effects for these people *:

  1. Headache (pain in head): 51 people, 62.20%
  2. Diarrhea: 43 people, 52.44%
  3. Nausea (feeling of having an urge to vomit): 40 people, 48.78%
  4. Breathing Difficulty: 27 people, 32.93%
  5. Pain In Jaw: 25 people, 30.49%
  6. Nausea And Vomiting: 21 people, 25.61%
  7. Dizziness: 18 people, 21.95%
  8. Fatigue (feeling of tiredness): 16 people, 19.51%
  9. Malaise (a feeling of general discomfort or uneasiness): 15 people, 18.29%
  10. Chest Pain: 14 people, 17.07%

* Approximation only. Some reports may have incomplete information.


Do you have Red face while taking Treprostinil?

You are not alone:




Related studies

Drugs that are associated with Red face
Red face (2,687 drugs)
Could your condition cause Red face
Red face (2,371 conditions)
Treprostinil side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Treprostinil
a b c d e f g h i j k l m n o p q r s t u v w x y z


What would happen?

Predict new side effects and undetected conditions when you take Treprostinil and have Red face



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.